Description
Marten Somatropin 50 IU (16.65 mg) is a recombinant human growth hormone (HGH), also known as somatropin, produced using recombinant DNA technology. It is structurally identical to endogenous human growth hormone, consisting of 191 amino acids, and plays a key role in growth, metabolism, and cellular repair processes.
This product is supplied as a lyophilized powder for injection, a format widely used to preserve the structural stability and biological activity of peptide hormones prior to reconstitution. Lyophilization helps maintain product integrity during storage and transport, ensuring long-term stability under appropriate conditions.
Somatropin is an essential hormone involved in multiple physiological functions, including protein synthesis, fat metabolism, bone density maintenance, and regulation of body composition. It also stimulates the production of insulin-like growth factor 1 (IGF-1), which mediates many of the biological effects associated with growth hormone activity.
Marten Somatropin is commonly referenced in scientific and research contexts related to endocrine function, recovery biology, and metabolic regulation. The 50 IU (16.65 mg) dosage provides a standardized quantity suitable for controlled environments and laboratory settings.
As with all growth hormone–related compounds, somatropin influences complex hormonal pathways and requires careful consideration in any context where it is studied or used. Individual responses may vary depending on biological and environmental factors.
The product should be stored under appropriate conditions to maintain its stability. Lyophilized somatropin is typically stored in a cool, dry place, protected from light, and reconstituted according to relevant guidelines when used in controlled settings.
This content is provided strictly for educational and informational purposes. Marten Somatropin is not intended for human consumption and should only be handled in accordance with applicable laboratory and research standards.